A study on the effect of combining genetic test and plasma amino acid test on promoting health care actions.
Not Applicable
- Conditions
- Metabolic syndrome and cancer
- Registration Number
- JPRN-UMIN000022358
- Lead Sponsor
- Ajinomoto Co., INC.
- Brief Summary
Combining the genetic testing "MYCODE" and "AminoIndexTM" screening test, based on plasma amino acid profile, raised health consciousness in mind and action compared to having either one of the tests.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
Not provided
Exclusion Criteria
1)Those who are pregnant, or breast feeding 2)Those who have congenital metabolic disorders 3)Those who are undergoing dialysis 4)Those who are participating in another clinical study 5)Those who have mental diseases or disorders and for whom doctors judged difficult to participate in the study. 6)Those for whom the doctor judged inappropriate to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analysis on the promoting effect of either single test or combination of genetic test and plasma amino acid test on taking health care actions by questionnaire survey before and 1 month after either test.
- Secondary Outcome Measures
Name Time Method Analysis on the promoting effect of the results of genetic and plasma amino acid test on taking health care actions by questionnaire survey before and 1 month after either test.